Inventor · Aston Rowant, GB

David Chaplin

18Patents
4h-index
28Co-inventors
60Inventor score

Filing activity: Apr 13, 1987 → Aug 31, 2016

Most-cited inventions

PatentTitleAreaCited byStatus
US4921963A Platinum complexes with one radiosensitizing ligand Human Necessities 37 Expired
US5026694A Platinum complexes with one radiosensitizing ligand Chemistry; Metallurgy 27 Expired
US6919324B2 Functionalized stilbene derivatives as improved vascular targeting agents Chemistry; Metallurgy 9 Expired
US7358236B1 Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents Human Necessities 4 Expired
US6028111A Compositions and use of benzamides and nicotinamides as anti-inflammatory agents Chemistry; Metallurgy 3 Expired
US8198302B2 Compositions and methods with enhanced therapeutic activity Chemistry; Metallurgy 2 Active
US8877967B2 Compositions and methods for inhibition of cathepsins Chemistry; Metallurgy 2 Active
US9873668B2 Compositions and methods for inhibition of cathepsins Chemistry; Metallurgy 2 Active
US7001926B2 Tubulin binding agents and corresponding prodrug constructs Chemistry; Metallurgy 1 Expired
US9040500B2 Method for treating hematopoietic neoplasms Human Necessities 1 Active
US7384925B2 Functionalized stilbene derivatives as improved vascular targeting agents Chemistry; Metallurgy 1 Expired
US7091240B2 Tubulin binding ligands and corresponding prodrug constructs Chemistry; Metallurgy 1 Expired
US7456214B2 Chromene-containing compounds with anti-tubulin and vascular targeting activity Human Necessities 1 Expired
US9458103B2 Compositions and methods for inhibition of cathepsins Chemistry; Metallurgy 1 Active
USRE45720E1 Functionalized stilbene derivatives as improved vascular targeting agents General 0 Active
USRE45907E1 Functionalized stilbene derivatives as improved vascular targeting agents General 0 Active
US11419934B2 Use of VDAS to enhance immunomodulating therapies against tumors Chemistry; Metallurgy 0 Active
US6713517B1 Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.